Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients

BACKGROUND: The COVID-19 pandemic due to SARS-CoV-2 infection can produce Acute Respiratory Distress Syndrome as a result of a pulmonary cytokine storm. Antihistamines are safe and effective treatments for reducing inflammation and cytokine release. Combinations of Histamine-1 and Histamine-2 recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Hogan II, Reed B., Hogan III, Reed B., Cannon, Tim, Rappai, Maria, Studdard, John, Paul, Doug, Dooley, Thomas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455799/
https://www.ncbi.nlm.nih.gov/pubmed/32871242
http://dx.doi.org/10.1016/j.pupt.2020.101942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455799/
https://www.ncbi.nlm.nih.gov/pubmed/32871242
http://dx.doi.org/10.1016/j.pupt.2020.101942

Ejemplares similares